$BIGC
BigCommerce Holdings, Inc.

2021 Q1 Form 10-K Financial Statement

#000156459021009501 Filed on February 26, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q4 2020 Q3
Revenue $46.66M $43.14M $39.74M
YoY Change 40.65% 39.08% 40.59%
Cost Of Revenue $9.250M $10.22M $8.593M
YoY Change 23.66% 26.67% 26.26%
Gross Profit $37.41M $32.93M $31.14M
YoY Change 45.6% 43.44% 45.13%
Gross Profit Margin 80.18% 76.32% 78.37%
Selling, General & Admin $32.42M $32.79M $29.07M
YoY Change 45.84% 50.75% 39.29%
% of Gross Profit 86.65% 99.58% 93.36%
Research & Development $13.54M $13.94M $12.12M
YoY Change 23.94% 27.2% 11.62%
% of Gross Profit 36.18% 42.34% 38.93%
Depreciation & Amortization $700.0K $700.0K $700.0K
YoY Change -22.22% -65.69% 16.67%
% of Gross Profit 1.87% 2.13% 2.25%
Operating Expenses $45.95M $46.73M $41.20M
YoY Change 38.62% 42.86% 29.82%
Operating Profit -$8.542M -$13.80M -$10.06M
YoY Change 14.58% 41.48% -2.16%
Interest Expense $10.00K $448.0K $741.0K
YoY Change -98.69% -7.25% 106.41%
% of Operating Profit
Other Income/Expense, Net -$14.00K $59.00K -$75.00K
YoY Change -93.1% -231.11% -12.79%
Pretax Income -$8.544M -$14.18M -$10.87M
YoY Change 113.28% 37.89% 1.41%
Income Tax $0.00 $19.00K -$14.00K
% Of Pretax Income
Net Earnings -$8.544M -$14.20M -$10.86M
YoY Change 112.38% 37.98% 1.21%
Net Earnings / Revenue -18.31% -32.92% -27.32%
Basic Earnings Per Share
Diluted Earnings Per Share -$122.4K -$207.2K -$160.2K
COMMON SHARES
Basic Shares Outstanding 68.53M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q4 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $208.0M $219.4M $178.8M
YoY Change 530.3%
Cash & Equivalents $189.6M $219.4M $178.8M
Short-Term Investments $18.40M
Other Short-Term Assets $11.30M $11.70M $12.70M
YoY Change 18.95%
Inventory
Prepaid Expenses
Receivables $26.10M $22.89M $21.50M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $245.4M $254.1M $212.9M
YoY Change 318.77% 702.22%
LONG-TERM ASSETS
Property, Plant & Equipment $18.10M $7.122M $19.60M
YoY Change -14.62% -13.58%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $5.400M $3.600M $3.000M
YoY Change 145.45%
Total Long-Term Assets $23.40M $22.55M $22.60M
YoY Change 0.0% -7.54%
TOTAL ASSETS
Total Short-Term Assets $245.4M $254.1M $212.9M
Total Long-Term Assets $23.40M $22.55M $22.60M
Total Assets $268.8M $276.6M $235.5M
YoY Change 227.8% 393.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.700M $5.788M $5.600M
YoY Change -21.67% 49.14%
Accrued Expenses $18.20M $3.344M $19.00M
YoY Change 61.06% -42.83%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $11.90M
YoY Change -100.0%
Total Short-Term Liabilities $40.10M $45.89M $52.50M
YoY Change 21.15% 35.3%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $10.00M
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $13.40M $14.00M $14.50M
YoY Change -14.65%
Total Long-Term Liabilities $13.40M $14.00M $24.50M
YoY Change -84.27% -63.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $40.10M $45.89M $52.50M
Total Long-Term Liabilities $13.40M $14.00M $24.50M
Total Liabilities $53.50M $59.87M $77.00M
YoY Change -54.78% -33.19%
SHAREHOLDERS EQUITY
Retained Earnings -$313.4M -$299.2M
YoY Change 14.15%
Common Stock $530.2M $457.7M
YoY Change 2974.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $215.3M $216.8M $158.5M
YoY Change
Total Liabilities & Shareholders Equity $268.8M $276.6M $235.5M
YoY Change 227.8% 393.41%

Cashflow Statement

Concept 2021 Q1 2020 Q4 2020 Q3
OPERATING ACTIVITIES
Net Income -$8.544M -$14.20M -$10.86M
YoY Change 112.38% 37.98% 1.21%
Depreciation, Depletion And Amortization $700.0K $700.0K $700.0K
YoY Change -22.22% -65.69% 16.67%
Cash From Operating Activities -$12.76M -$3.330M -$6.210M
YoY Change 27.71% -88.45%
INVESTING ACTIVITIES
Capital Expenditures -$480.0K -$580.0K -$330.0K
YoY Change -20.0% -86.76%
Acquisitions
YoY Change
Other Investing Activities -$18.37M $0.00
YoY Change
Cash From Investing Activities -$18.85M -$580.0K -$330.0K
YoY Change 3058.12% -108.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.741M 44.54M 160.0M
YoY Change -95.1% 218.83%
NET CHANGE
Cash From Operating Activities -12.76M -3.330M -6.210M
Cash From Investing Activities -18.85M -580.0K -330.0K
Cash From Financing Activities 1.741M 44.54M 160.0M
Net Change In Cash -29.87M 40.63M 153.5M
YoY Change -219.67% -608.51%
FREE CASH FLOW
Cash From Operating Activities -$12.76M -$3.330M -$6.210M
Capital Expenditures -$480.0K -$580.0K -$330.0K
Free Cash Flow -$12.28M -$2.750M -$5.880M
YoY Change 30.76% -88.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2704000
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1786000
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18636000
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
9399000
CY2020Q4 us-gaap Assets
Assets
276626000
CY2019Q4 us-gaap Assets
Assets
56064000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3173000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5788000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3881000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3344000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5849000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
45887000
CY2020Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1308000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
22176000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15705000
CY2019Q4 us-gaap Liabilities
Liabilities
89613000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
17244000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-274549000
CY2018 us-gaap Cost Of Revenue
CostOfRevenue
21937000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-257303000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56064000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
91867000
CY2019 us-gaap Interest Expense
InterestExpense
1612000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-37560000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-42590000
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78726
CY2020 dei City Area Code
CityAreaCode
512
CY2020 dei Local Phone Number
LocalPhoneNumber
865-4500
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
68528926
CY2021Q1 dei Entity Public Float
EntityPublicFloat
4600000000
CY2020 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
219447000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7795000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1160000
CY2019Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1355000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22894000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15548000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8000000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5296000
CY2020Q4 bigc Deferred Commissions Current
DeferredCommissionsCurrent
2571000
CY2019Q4 bigc Deferred Commissions Current
DeferredCommissionsCurrent
1677000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
254072000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
31671000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7122000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8241000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11842000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14065000
CY2019Q4 bigc Deferred Commissions Noncurrent
DeferredCommissionsNoncurrent
2087000
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
11406000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2363000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2718000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9704000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
33914000
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1492000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
38502000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
7000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
530143000
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
34126000
CY2019 us-gaap Gross Profit
GrossProfit
85080000
CY2018 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
45928000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48332000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36137000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22204000
CY2020 us-gaap Operating Expenses
OperatingExpenses
156939000
CY2019 us-gaap Operating Expenses
OperatingExpenses
126067000
CY2018 us-gaap Operating Expenses
OperatingExpenses
107910000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-38697000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-40987000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-37980000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
31000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
245000
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
653000
CY2020 us-gaap Interest Expense
InterestExpense
3103000
CY2018 us-gaap Interest Expense
InterestExpense
1489000
CY2020 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
4413000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-179000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-208000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-52000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37535000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-42562000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38868000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-38878000
CY2020 bigc Cumulative Dividends And Accretion Of Issuance Costs
CumulativeDividendsAndAccretionOfIssuanceCosts
962000
CY2019 bigc Cumulative Dividends And Accretion Of Issuance Costs
CumulativeDividendsAndAccretionOfIssuanceCosts
7308000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
171129000
CY2018 bigc Cumulative Dividends And Accretion Of Issuance Costs
CumulativeDividendsAndAccretionOfIssuanceCosts
4712000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-38522000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-49898000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-43590000
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.99
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.80
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.59
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39092000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17834000
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16807000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
14000
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-14000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-37560000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-42576000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-38892000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-171714000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
607000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2071000
CY2018 bigc Changes In Preferred Stock Dividends
ChangesInPreferredStockDividends
4662000
CY2018 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
50000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-211476000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
901000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3156000
CY2019 bigc Changes In Preferred Stock Dividends
ChangesInPreferredStockDividends
7234000
CY2019 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
74000
CY2020 bigc Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
126000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11058000
CY2020 bigc Stock Issued During Period Value Secondary Public Offering Issues
StockIssuedDuringPeriodValueSecondaryPublicOfferingIssues
65112000
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
211902000
CY2020 bigc Stock Issued During Period Value Conversion Of Convertible Debt Securities
StockIssuedDuringPeriodValueConversionOfConvertibleDebtSecurities
50173000
CY2020 bigc Changes In Preferred Stock Dividends
ChangesInPreferredStockDividends
918000
CY2020 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
44000
CY2020 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
297000
CY2020 us-gaap Profit Loss
ProfitLoss
-37560000
CY2019 us-gaap Profit Loss
ProfitLoss
-42590000
CY2018 us-gaap Profit Loss
ProfitLoss
-38878000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3084000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2569000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1844000
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
774000
CY2019 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
54000
CY2018 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
49000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
11058000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
3156000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
2071000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1594000
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
988000
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
341000
CY2019 bigc Accretion On Discount To Marketable Securities
AccretionOnDiscountToMarketableSecurities
69000
CY2018 bigc Accretion On Discount To Marketable Securities
AccretionOnDiscountToMarketableSecurities
190000
CY2020 us-gaap Increase Decrease In Financial Instruments Used In Operating Activities
IncreaseDecreaseInFinancialInstrumentsUsedInOperatingActivities
4413000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9305000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6297000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4627000
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
171129000
CY2020 bigc Proceeds From Issuance Secondary Public Offering
ProceedsFromIssuanceSecondaryPublicOffering
65112000
CY2020 us-gaap Payments Of Dividends
PaymentsOfDividends
12814000
CY2020 bigc Proceeds From Exercise Of Stock Options And Warrants
ProceedsFromExerciseOfStockOptionsAndWarrants
3279000
CY2019Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12201000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12590000
CY2019 bigc Proceeds From Exercise Of Stock Options And Warrants
ProceedsFromExerciseOfStockOptionsAndWarrants
901000
CY2020 bigc Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
2396000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
291000
CY2019 bigc Increase Decrease In Accrued And Other Current Liabilities
IncreaseDecreaseInAccruedAndOtherCurrentLiabilities
8164000
CY2018 bigc Increase Decrease In Accrued And Other Current Liabilities
IncreaseDecreaseInAccruedAndOtherCurrentLiabilities
2351000
CY2020 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1822000
CY2019 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1673000
CY2018 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
6908000
CY2018 bigc Increase Decrease In Other Operating Assets And Liabilities
IncreaseDecreaseInOtherOperatingAssetsAndLiabilities
347000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26529000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39969000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30591000
CY2018 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
33566000
CY2020 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
1964000
CY2019 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
5579000
CY2018 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
3326000
CY2019 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
23450000
CY2018 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
10375000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1964000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
17871000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26517000
CY2018 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
63629000
CY2018 bigc Proceeds From Exercise Of Stock Options And Warrants
ProceedsFromExerciseOfStockOptionsAndWarrants
607000
CY2020 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
41861000
CY2019 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
18500000
CY2018 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
4500000
CY2020 us-gaap Repayments Of Debt
RepaymentsOfDebt
28617000
CY2019 us-gaap Repayments Of Debt
RepaymentsOfDebt
2050000
CY2018 us-gaap Repayments Of Debt
RepaymentsOfDebt
4500000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
239950000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17351000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
64236000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
211457000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4747000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7128000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9150000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13897000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6769000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
220607000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
2285000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
1626000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
1250000
CY2020 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
211902000
CY2020 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
50173000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13485000
CY2018Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
6200000
CY2020 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10395000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3100000
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2806000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
15845000
CY2020Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
814000
CY2019Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
551000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18255000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2600000
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with GAAP requires certain financial instruments to be recorded at fair value; requires our management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenue and expenses during the reporting periods. Significant estimates, judgments, and assumptions in these consolidated financial statements include: allocating variable consideration for revenue recognition; the amortization period for deferred commissions; the allowance<font style="font-size:12pt;"> </font>for credit losses; a determination of the deferred tax asset valuation allowance and the valuation of our common stock used to determine stock-based compensation expense prior to our IPO. Because of the use of estimates inherent in the financial reporting process and given the additional or unforeseen effects from the COVID-19 pandemic, actual results could differ from those estimates, and such differences could be material to our consolidated financial statements.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">COVID-19, declared a global pandemic by the World Health Organization on March&#160;11, 2020, has caused disruption to the economies and communities of the United States and our target international markets. In the interest of public health, many governments closed physical stores and places of business deemed non-essential. This precipitated a significant shift in shopping behavior from offline to online. Our business has benefited from this shift, both in accelerated sales growth for our existing customers&#8217; stores, and in our sales of new store subscriptions to customers. Nevertheless, we do not have certainty that those trends will continue; the COVID-19 pandemic and the uncertainty it has created in the global economy could materially adversely affect our business, financial condition, and results of operations.</p>
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1800000
CY2020Q4 us-gaap Recorded Unconditional Purchase Obligation Due Within One Year
RecordedUnconditionalPurchaseObligationDueWithinOneYear
6122000
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Concentration of credit risks, significant clients, and suppliers</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject us to concentrations of credit risk consist of cash and cash equivalents, restricted cash, and accounts receivable. Our investment policy limits investments to high credit quality securities issued by the U.S. government, U.S. government-sponsored agencies, and highly rated corporate securities, subject to certain concentration limits and restrictions on maturities. Our cash and cash equivalents and restricted cash are held by financial institutions that management believes are of high credit quality. Amounts on deposit may at times exceed federally insured limits. We have not experienced any losses on our deposits of cash and cash equivalents. We are exposed to credit risk in the event of default by the financial institutions holding our cash and cash equivalents and bond issuers.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable are derived from sales to our customers and our strategic technology partners who operate in a variety of sectors. We do not require collateral. Estimated credit losses are provided for in the consolidated financial statements and historically have been within management&#8217;s expectations.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">One of our strategic partners accounted for 15% of our revenue for the year ended December 31, 2020 and 12% of our revenue for each of the years ended December&#160;31, 2019 and 2018, and accounted for 24%, 20% and 22% of our accounts receivable balance at December&#160;31, 2020, 2019 and 2018, respectively.</p>
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.17
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.98
CY2020Q4 us-gaap Recorded Unconditional Purchase Obligation Due In Second Year
RecordedUnconditionalPurchaseObligationDueInSecondYear
4333000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.22
CY2020Q4 us-gaap Recorded Unconditional Purchase Obligation
RecordedUnconditionalPurchaseObligation
10455000
CY2020Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2019Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2020 bigc Lease Operating Lease Expiration Year
LeaseOperatingLeaseExpirationYear
2028
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6126000
CY2020Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
3107000
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
14.85
CY2019Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
3027000
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.25
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.33
CY2020Q1 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
4413000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.30
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.03
CY2020 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
2200000
CY2019 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
1600000
CY2020 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
0
CY2019 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
900000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.99
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y7M6D
CY2018 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
1200000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.01
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y2M1D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M24D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y6M29D
CY2020 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2013-02-28
CY2020Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
7500000
CY2019Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
4000000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
376000
CY2018 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
120000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
597000
CY2019 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
418000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1167000
CY2020 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1133000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1992000
CY2020 bigc Concentration Risk Number Of Customer
ConcentrationRiskNumberOfCustomer
1
CY2019 bigc Concentration Risk Number Of Customer
ConcentrationRiskNumberOfCustomer
1
CY2018 bigc Concentration Risk Number Of Customer
ConcentrationRiskNumberOfCustomer
1
CY2020 us-gaap Advertising Expense
AdvertisingExpense
12900000
CY2019 us-gaap Advertising Expense
AdvertisingExpense
11800000
CY2018 us-gaap Advertising Expense
AdvertisingExpense
8900000
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
86900000
CY2020Q4 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.55
CY2020Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2020 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
We expect to recognize approximately 55% of the remaining performance obligations as revenue in the next 12 months, and the remaining balance in the periods thereafter.
CY2020 bigc Amortization Of Deferred Sales Commissions Estimated Period
AmortizationOfDeferredSalesCommissionsEstimatedPeriod
P4Y
CY2020 bigc Impairment Of Deferred Commissions
ImpairmentOfDeferredCommissions
0
CY2019 bigc Impairment Of Deferred Commissions
ImpairmentOfDeferredCommissions
0
CY2020Q4 bigc Deferred Sales Commissions
DeferredSalesCommissions
4500000
CY2019Q4 bigc Deferred Sales Commissions
DeferredSalesCommissions
2500000
CY2018Q4 bigc Deferred Sales Commissions
DeferredSalesCommissions
2000000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2243000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2011000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20607000
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
3700000
CY2019 us-gaap Operating Lease Expense
OperatingLeaseExpense
3200000
CY2018 us-gaap Operating Lease Expense
OperatingLeaseExpense
2500000
CY2020 bigc Operating Lease Short Term Rent Expenses
OperatingLeaseShortTermRentExpenses
400000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1408000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1408000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
24.67
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
24.67
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11058000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3156000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
4923000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
18651000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2071000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019 bigc Operating Lease Short Term Rent Expenses
OperatingLeaseShortTermRentExpenses
300000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
3666000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
3224000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2714000
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y9M18D
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0542
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0550
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3928000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3062000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2484000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.20
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.42
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9006000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2266000
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1099000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
846000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9327000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1384000
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2053000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
443000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8215000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
7578000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
4072000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.71
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.45
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y10M6D
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
13327000
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
65294000
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
491648000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
456531000
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
253117000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
72400000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5600000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2600000
CY2020Q4 bigc Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrossFairValue
9600000
CY2019Q4 bigc Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrossFairValue
8100000
CY2018Q4 bigc Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrossFairValue
6300000
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
11400000
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
9400000
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0345
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-31891000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-38720000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
25000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
28000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-38471000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-5644000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
10000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.0066
CY2019 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.0033
CY2018 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0015
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-3842000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-397000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-37535000
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-42562000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-38868000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
25000
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
10000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1000
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.0497
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.0324
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
3000
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
24000
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.0046
CY2020 bigc Effective Income Tax Rate Reconciliation Excess Tax Benefits Relating To Stock Based Compensation
EffectiveIncomeTaxRateReconciliationExcessTaxBenefitsRelatingToStockBasedCompensation
0.1697
CY2019 bigc Effective Income Tax Rate Reconciliation Excess Tax Benefits Relating To Stock Based Compensation
EffectiveIncomeTaxRateReconciliationExcessTaxBenefitsRelatingToStockBasedCompensation
0.0038
CY2018 bigc Effective Income Tax Rate Reconciliation Excess Tax Benefits Relating To Stock Based Compensation
EffectiveIncomeTaxRateReconciliationExcessTaxBenefitsRelatingToStockBasedCompensation
-0.0083
CY2020 bigc Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.0817
CY2019 bigc Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.0377
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0491
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0325
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2018 bigc Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.0183
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.4041
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2450
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2230
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0109
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0007
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0007
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0003
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
52216000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
36373000
CY2020Q4 bigc Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
3868000
CY2019Q4 bigc Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
3854000
CY2020Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
426000
CY2019Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
871000
CY2020Q4 bigc Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
8381000
CY2019Q4 bigc Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
9144000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2401000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
682000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1721000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
702000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
69013000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
51626000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
62917000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
46784000
CY2019Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Software
DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware
478000
CY2020Q4 bigc Deferred Tax Liabilities Deferred Commission
DeferredTaxLiabilitiesDeferredCommission
1448000
CY2019Q4 bigc Deferred Tax Liabilities Deferred Commission
DeferredTaxLiabilitiesDeferredCommission
752000
CY2020Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
2904000
CY2020 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2019Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
2887000
CY2020Q4 bigc Deferred Tax Liabilities Prepaid Expenses And Other
DeferredTaxLiabilitiesPrepaidExpensesAndOther
1744000
CY2019Q4 bigc Deferred Tax Liabilities Prepaid Expenses And Other
DeferredTaxLiabilitiesPrepaidExpensesAndOther
725000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
6096000
CY2019 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
28264000
CY2020 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27235000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25584000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
4842000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
168900000
CY2020 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0
CY2020Q4 bigc Deferred Tax Assets Operating Loss Carryforwards Domestic Prior Year
DeferredTaxAssetsOperatingLossCarryforwardsDomesticPriorYear
120400000
CY2019Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10961000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10862000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10468000
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9623000
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
46313000
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
45980000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33174000
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31020000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10832000
CY2020Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12212000
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
43143000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9745000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7714000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6466000
CY2019Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6456000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5527000
CY2020Q4 bigc Deferred Tax Assets Operating Loss Carryforwards Domestic To Future Period
DeferredTaxAssetsOperatingLossCarryforwardsDomesticToFuturePeriod
48500000
CY2020 bigc Operating Loss Carryforwards Expiration Year
OperatingLossCarryforwardsExpirationYear
2036
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
66500000
CY2020 bigc Net Operating Loss Carryforwards Expiration Year
NetOperatingLossCarryforwardsExpirationYear
2036
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
11400000
CY2020Q4 bigc Deferred Tax Assets Tax Credit Carryforwards Research And Development Domestic
DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentDomestic
5200000
CY2020 bigc Tax Credits Begin To Expiration Year
TaxCreditsBeginToExpirationYear
2034
CY2020Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
16100000
CY2020 us-gaap Income Tax Examination Year Under Examination
IncomeTaxExaminationYearUnderExamination
2017 2018 2019 2020
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39735000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36316000
CY2020Q4 us-gaap Cost Of Revenue
CostOfRevenue
10216000
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
8593000
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
7837000
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
7480000
CY2019Q4 us-gaap Cost Of Revenue
CostOfRevenue
8065000
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
6806000
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
6227000
CY2019Q1 us-gaap Cost Of Revenue
CostOfRevenue
5925000
CY2020Q4 us-gaap Gross Profit
GrossProfit
32927000
CY2020Q3 us-gaap Gross Profit
GrossProfit
31142000
CY2020Q2 us-gaap Gross Profit
GrossProfit
28479000
CY2020Q1 us-gaap Gross Profit
GrossProfit
25694000
CY2019Q4 us-gaap Gross Profit
GrossProfit
22955000
CY2019Q3 us-gaap Gross Profit
GrossProfit
21458000
CY2019Q2 us-gaap Gross Profit
GrossProfit
21008000
CY2019Q1 us-gaap Gross Profit
GrossProfit
19659000
CY2020Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20577000
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
19328000
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16803000
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15762000
CY2019Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15295000
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15346000
CY2019Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15963000
CY2019Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14136000
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13942000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12124000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11345000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10921000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7455000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
33149000
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
32712000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5222000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4999000
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
46731000
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-9757000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10277000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-10645000
CY2019Q4 us-gaap Interest Expense
InterestExpense
483000
CY2019Q3 us-gaap Interest Expense
InterestExpense
359000
CY2019Q2 us-gaap Interest Expense
InterestExpense
410000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
41197000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
35862000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10308000
CY2020Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
11000
CY2019Q1 us-gaap Interest Expense
InterestExpense
360000
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
17000
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
4000
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
86000
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
155000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12830000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-4023000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-10292000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
31735000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
31653000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
29967000
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-13804000
CY2020Q4 us-gaap Interest Expense
InterestExpense
448000
CY2020Q3 us-gaap Interest Expense
InterestExpense
741000
CY2020Q2 us-gaap Interest Expense
InterestExpense
1152000
CY2020Q1 us-gaap Interest Expense
InterestExpense
762000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10055000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7383000
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
59000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-75000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
40000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-203000
CY2019Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-45000
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-86000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-56000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-21000
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14182000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10869000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8478000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4006000
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10285000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10718000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11025000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10534000
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-14000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-14201000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-10855000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-8481000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12277000
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.54
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.67
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.70
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-10725000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-11032000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-10541000
CY2020Q3 bigc Cumulative Dividends And Accretion Of Issuance Costs
CumulativeDividendsAndAccretionOfIssuanceCosts
-2732000
CY2020Q2 bigc Cumulative Dividends And Accretion Of Issuance Costs
CumulativeDividendsAndAccretionOfIssuanceCosts
1953000
CY2020Q1 bigc Cumulative Dividends And Accretion Of Issuance Costs
CumulativeDividendsAndAccretionOfIssuanceCosts
1745000
CY2019Q4 bigc Cumulative Dividends And Accretion Of Issuance Costs
CumulativeDividendsAndAccretionOfIssuanceCosts
1909000
CY2019Q3 bigc Cumulative Dividends And Accretion Of Issuance Costs
CumulativeDividendsAndAccretionOfIssuanceCosts
1865000
CY2019Q2 bigc Cumulative Dividends And Accretion Of Issuance Costs
CumulativeDividendsAndAccretionOfIssuanceCosts
1798000
CY2019Q1 bigc Cumulative Dividends And Accretion Of Issuance Costs
CumulativeDividendsAndAccretionOfIssuanceCosts
1736000
CY2020Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14201000
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.73
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.70
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8123000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10434000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5768000
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19149000
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
49355000
CY2020Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
68638000
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
18645000
CY2019Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
18286000
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17959000
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17592000
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17487000

Files In Submission

Name View Source Status
0001564590-21-009501-index-headers.html Edgar Link pending
0001564590-21-009501-index.html Edgar Link pending
0001564590-21-009501.txt Edgar Link pending
0001564590-21-009501-xbrl.zip Edgar Link pending
bigc-10k_20201231.htm Edgar Link pending
bigc-20201231.xml Edgar Link completed
bigc-20201231.xsd Edgar Link pending
bigc-20201231_cal.xml Edgar Link unprocessable
bigc-20201231_def.xml Edgar Link unprocessable
bigc-20201231_lab.xml Edgar Link unprocessable
bigc-20201231_pre.xml Edgar Link unprocessable
bigc-ex1017_158.htm Edgar Link pending
bigc-ex1018_159.htm Edgar Link pending
bigc-ex231_156.htm Edgar Link pending
bigc-ex311_8.htm Edgar Link pending
bigc-ex312_9.htm Edgar Link pending
bigc-ex321_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g0q4pvfawenw000001.jpg Edgar Link pending
ghent024nyui000001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending